Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Myo-P3
- Development stage
- Preclinical
- Lead developer
- Release Therapeutics
- Modality
- Cell Therapies
- Administration
- Implant
01
Overview
Myo-P3 is an investigational encapsulated cell therapy developed by Release Therapeutics for the treatment of advanced melanoma. The therapy utilizes the company's proprietary Encapsulation Cell Technology (ECT), which consists of genetically engineered cells housed within a semi-permeable polymer capsule. These cells are designed to continuously produce and secrete an anti-CTLA-4 monoclonal antibody directly into the patient's system. By providing a steady, long-term release of the checkpoint inhibitor, Myo-P3 aims to maintain therapeutic levels of the drug while potentially minimizing the peak-related toxicities and dosing frequency associated with traditional intravenous administrations of CTLA-4 inhibitors like ipilimumab.
- Brand names
- Myo-P3Myo-P-3Myo-P 3
- Other names
- Myo-P3Myo-P-3Myo-P 3
02
Targets
CTLA-4 (Cytotoxic t-lymphocyte–associated protein 4)
Beyond the preview
Go deeper on Myo-P3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myo-P3.